Wednesday, January 27, 2021
1:00 pm - 2:00 pm
Dr. Shaker A. Mousa. Ph. D. will lead the discussion on the utilization of nanotechnology for the development of new nano-carrier systems has the potential to offer improved active targeted delivery.
Targeted delivery of drug incorporated nanoparticles, through conjugation of site-specific cell surface markers, such as site-specific antibodies, aptamer or ligands, which can enhance the efficacy of the anticancer drug and reduce the side effects. Additionally, multifunctional characteristics of the nano-carrier system would allow for simultaneous functiona imaging, therapeutics and monitoring (Theranostics). A summary of recent progress in nanotechnology as it relates to nanoparticles and drug delivery will be reviewed. Additionally, various Nanomedicine approaches for the early detection (predication), prevention and personalized treatment of various types of oncological, hematological and vascular targeting will be discussed. More information.
This webinar is free, but registration is required.